Pr Benoit You
@benoityoulyon
Followers
535
Following
239
Media
39
Statuses
2K
Oncologue medical spécialisé en essais cliniques de phase 1, CITOHL, phase 1 and 2 trials
Pierre-Bénite, France
Joined October 2016
It is the 1st episode of a saga that will question the interactions between #ovarian cancer biology, #cytoreductive surgery, #HIPEC, #chemosensitivity, and #maintenance in 1st line. This is like a comprehensive and dynamic PUZZLE ! @Salvovar_eu @ArcagyGineco @OvCancerDay
🎥 New on @VuMedi: Ovarian Cancer Biomarkers – What Does KELIM Reveal About CA-125 Kinetics? Dr. Benoit You explains how KELIM™ modeling refines prognosis & guides treatment in ovarian cancer. ➡️ Watch here: https://t.co/Fns4GHdKcc
#OvarianCancer #KELIM #CA125
0
0
2
Congrats Ainhoa !
Back from an inspiring #ESMOGynae25 🇦🇹 Fantastic opportunity to learn from 🔝 faculty & Network Honoured to receive the #BestPoster award @H12Octubre & share an #ADC session with Philip Harter & Christian Marth
1
0
5
Delighted to be the young representative at the #GCIG #pragmatictrial brainstorming session with @anacveneziani With 🔝 chairs Helen Mackey & Ros Glasspool
1
3
32
📅 May 28, 2025| GCIG – Gynecologic Cancer InterGroup ARCAGY-GINECO, is attending the annual GCIG meeting in Chicago, bringing together leading experts from around the world to advance research in gynecologic cancers. This meeting focus on the design and conduct of pragmatic
0
2
4
🆕article in press: 9MW2821, a next-generation nectin-4-targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase I/II study https://t.co/IUlInbT2BB
0
7
27
Some #ovarian cancer pts may benefit from #immunotherapy! 🧬 In #IMagyn050, pts with suboptimally resected & unfavorable #KELIM <1.0 may have had a PFS benefit. Align with #KEYLYNK001. Soon #FIRST trial results at #ASCO25! @ArcagyGineco @Salvovar_eu 🔗
0
1
2
We definitely have to find solutions for #ovarian cancer patients who have a poorly chemosensitive disease (unfavorable #KELIM <1.0) that is not amenable to a complete interval cytoreductive surgery ! @ArcagyGineco @Salvovar_eu @CHUdeLyon
Good news! Our has been accepted for a poster presentation at the ASCO 2025 Annual Meeting in the Trials In Progress session! Thanks to all who made this happen! #ASCO25 #ClinicalResearch #OvarianCancer #ClinicalTrials #SalvOvar #EUCancerMission
0
0
2
🗓️ 27 mars - 19èmes Rencontres Scientifiques du GINECO. Nous sommes très heureux de vous accueillir ! Coup d’envoi de ces journées avec la session ARC. Au programme des présentations sur : 💊les différents types de médicaments anti-cancéreux - Laura Mansi 🔬 la vie d’un
0
2
1
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced #OvarianCancer: ASCO Guideline update
ascopubs.org
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO...
0
8
20
#CA125 #KELIM cited as an indicator of the neoadj chemo efficacy in #ovarian cancer by @ASCO . Used for > 25,000 pts/year worldwide on https://t.co/49SpFAobfc @ArcagyGineco @CHUdeLyon @Salvovar_eu @OvCancerDay
1
2
5
📅 À l’occasion des Cours St Paul, le réseau GINECO s’est réuni pour un moment d’échange et de réflexion collective. 🧠💡 Cette réunion a permis aux membres de partager leurs idées ainsi que leurs perspectives sur les #enjeux #scientifiques majeurs de demain. Ensemble, nous
0
2
1
Toute l'équipe d'ARCAGY-GINECO vous souhaite une bonne année 2025 ! ✨ ----- ARCAGY-GINECO wishes you a Happy New Year 2025! ✨
0
1
1
Les HCL suspendent leur activité sur X : les conditions actuelles ne permettent plus d'assurer un cadre de partage d’information respectueux et constructif. ➡️ Retrouvez-nous sur nos autres réseaux pour continuer à échanger sur la #santé :
4
7
24
Quand le Centre Psychothérapique de Nancy et le CHRU de Nancy font la une du magazine Le Point grâce à l’incroyable Pre Coraline Hingray!! Elle est la cheffe de service de la Maison de la Résilience, dispositif unique en France. Nous sommes tous très fiers!!
2
12
46
Indeed we have to propose therapeutic solutions for patients with #ovarian cancer whose neoadjuvant chemotherapy is not effective enough. @ArcagyGineco @CHUdeLyon @Salvovar_eu
🌏 #International start of the @Salvovar_eu /ENGOT-ov78 study : after #France, we are now happy to announce the first patient at the international level and this is a Japanese #patient ! We are impatient to see the other countries starting soon (Italy, Israël and Netherlands and
0
0
4
🌏 #International start of the @Salvovar_eu /ENGOT-ov78 study : after #France, we are now happy to announce the first patient at the international level and this is a Japanese #patient ! We are impatient to see the other countries starting soon (Italy, Israël and Netherlands and
0
2
3
It has been lovely to participate in the @ESOncology Masterclass in Clinical Oncology in Venice 🇮🇹 🔸Great group of global young oncologists 🌍 🔸Amazing gyne cancer chair @Ilaria_Colombo_ & organization
0
2
25
The Colombia tour continues. Meeting in Bogota involving Dr Vargas and Dr Pierre leading a new Colombian group of centers specialized in gynecological cancers. Nice collaborations to build together ! @ArcagyGineco @CHUdeLyon @Salvovar_eu
1
0
4
The Colombia tour continues … visit #2 to the oncology and gynecology team at Instituto Nacional De Cancerologia ESE in Bogota ! Great discussion about the recent data on #ovarian cancer management… @ArcagyGineco @CHUdeLyon @Salvovar_eu
1
0
6